Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/11973
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHanney, S-
dc.contributor.authorSoper, B-
dc.contributor.authorJones, TH-
dc.contributor.authorBoaz, A-
dc.date.accessioned2016-01-29T14:37:35Z-
dc.date.available2016-01-29T14:37:35Z-
dc.date.issued2015-
dc.identifier.citationBMJ, 351 pp. H6931 - H6931, (2015)en_US
dc.identifier.issn1756-1833-
dc.identifier.urihttp://www.bmj.com/content/351/bmj.h6931.full.pdf+html-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/11973-
dc.description.abstractIn Editor’s Choice, Godlee supports and re-emphasises the positive points about National Institute for Health Research (NIHR) clinical research networks that are made in Gulland’s article.1 2 We welcome this support for research networks and for the part they can play in a more fully integrated research and healthcare system. Research engagement by clinicians and healthcare organisations is widely held to improve health services performance. However, we found the issue to be complex in our review conducted for the NIHR Health Services and Delivery Research (HS&DR) Programme in 2012-13.3 Thirty three papers were included in the analysis, and 28 were positive about improved performance, although only seven identified improved outcomes rather than improved processes. Diverse mechanisms contributed to these improvements. In a subsequent article we consider more recent evidence,4 including that UK NHS trusts active in research have lower risk adjusted mortality for acute admissions.5 Increased attention to this issue covers not only clinician participation but also organisational developments in the NIHR and NHS, such as Collaborations for Leadership in Applied Health Research and Care (CLAHRC) and Academic Health Science Networks (AHSNs).6 7 These seek to promote better integration of research and healthcare systems by strengthening research networks, developing research capacity, and ensuring that healthcare organisations (both providers and commissioners) see research as an integral component of their overall structure. Such initiatives need to be linked to further empirical analysis that considers not only the research engagement of all relevant actors but also the organisational determinants of the impact on practice of such engagement.en_US
dc.format.extentH6931 - H6931-
dc.language.isoenen_US
dc.publisherBMJ Publishing Group: BMJen_US
dc.titleBenefits from clinicians and healthcare organisations engaging in researchen_US
dc.typeOtheren_US
dc.identifier.doihttp://dx.doi.org/10.1136/bmj.h6931-
dc.relation.isPartOfBMJ-
pubs.confidentialfalse-
pubs.confidentialfalse-
pubs.publication-statusPublished-
pubs.publication-statusPublished-
pubs.start-date2015-12-23-
pubs.start-date2015-12-23-
pubs.volume351-
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdf478.74 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.